17.99
price up icon0.28%   0.05
after-market Handel nachbörslich: 17.98 -0.010 -0.06%
loading

Summit Therapeutics Inc Aktie (SMMT) Neueste Nachrichten

pulisher
11:24 AM

Citi Asserts Buy Rating on Summit Therapeutics Inc. (SMMT) on Pipeline Development - Yahoo Finance

11:24 AM
pulisher
08:04 AM

Citi asserts buy rating on Summit Therapeutics Inc. (SMMT) on pipeline development - MSN

08:04 AM
pulisher
03:14 AM

Has Summit Therapeutics Rally Left Enough Upside After 448.6% Surge and DCF Upswing? - Yahoo Finance

03:14 AM
pulisher
Dec 09, 2025

2 Stocks Up Over 600% in the Past 3 Years With More Room to Run - Finviz

Dec 09, 2025
pulisher
Dec 09, 2025

U.S. Markets Ended Tuesday Mixed As Galaxy Digital Led, Summit Therapeutics Lagged - Barron's

Dec 09, 2025
pulisher
Dec 08, 2025

Norges Bank Invests $29.58 Million in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 08, 2025
pulisher
Dec 07, 2025

New York State Common Retirement Fund Buys 227,513 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Dec 07, 2025
pulisher
Dec 06, 2025

Schroder Investment Management Group Sells 89,090 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

State Board of Administration of Florida Retirement System Boosts Stake in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 06, 2025
pulisher
Dec 05, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Dec 05, 2025
pulisher
Dec 05, 2025

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? - Finviz

Dec 05, 2025
pulisher
Dec 05, 2025

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? - The Motley Fool

Dec 05, 2025
pulisher
Dec 05, 2025

Why analysts upgrade Summit Therapeutics Inc. stockJuly 2025 Earnings & Weekly Chart Analysis and Guides - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Summit Therapeutics Inc. (SMMT) Options Chain - Yahoo! Finance Canada

Dec 05, 2025
pulisher
Dec 04, 2025

1 Reason I'll Never Sell Vertex Pharmaceuticals Stock - AOL.com

Dec 04, 2025
pulisher
Dec 04, 2025

Summit Therapeutics (NASDAQ:SMMT) Trading 9.2% HigherShould You Buy? - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Can Summit Therapeutics Inc. stock maintain operating marginsWeekly Gains Report & AI Powered Market Trend Analysis - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Summit Therapeutics Earnings Notes - Trefis

Dec 04, 2025
pulisher
Dec 03, 2025

Don't Buy Summit Therapeutics Until This Big Thing Happen - Yahoo Finance

Dec 03, 2025
pulisher
Dec 02, 2025

Widening Q3 Losses and Insider Buying Might Change The Case For Investing In Summit Therapeutics (SMMT) - Yahoo Finance

Dec 02, 2025
pulisher
Dec 02, 2025

Summit Therapeutics (SMMT): Valuation Check After Weak Q3 2025 Results and Insider Share Purchases - Yahoo Finance

Dec 02, 2025
pulisher
Dec 02, 2025

How Summit Therapeutics Inc. (SMMT) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Dec 02, 2025
pulisher
Dec 02, 2025

SMMT: Four positive phase 3 trials and accelerated timelines position the pipeline for NSCLC market leadership - TradingView

Dec 02, 2025
pulisher
Dec 02, 2025

XTX Topco Ltd Makes New $925,000 Investment in Summit Therapeutics PLC $SMMT - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

2 Monster Stocks in the Making to Buy and Hold - The Globe and Mail

Dec 02, 2025
pulisher
Dec 02, 2025

Summit Therapeutics: InvestingPro’s Fair Value model predicted 37% downside By Investing.com - Investing.com Nigeria

Dec 02, 2025
pulisher
Dec 01, 2025

Summit Therapeutics (SMMT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Nov 29, 2025

33,096 Shares in Summit Therapeutics PLC $SMMT Acquired by Inceptionr LLC - MarketBeat

Nov 29, 2025
pulisher
Nov 27, 2025

Rhenman & Partners Asset Management AB Makes New Investment in Summit Therapeutics PLC $SMMT - MarketBeat

Nov 27, 2025
pulisher
Nov 27, 2025

Summit Therapeutics PLC (NASDAQ:SMMT) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

WE Convention 2025: Dr. Maky Zanganeh, Co-CEO and President, Summit Therapeutics - Entrepreneur

Nov 26, 2025
pulisher
Nov 26, 2025

January 2026 Options Now Available For Summit Therapeutics (SMMT) - Nasdaq

Nov 26, 2025
pulisher
Nov 25, 2025

Summit Therapeutics Inc. (SMMT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 25, 2025
pulisher
Nov 25, 2025

Cynosure Group LLC Buys Shares of 18,609 Summit Therapeutics PLC $SMMT - MarketBeat

Nov 25, 2025
pulisher
Nov 24, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Nov 24, 2025
pulisher
Nov 23, 2025

40,169 Shares in Summit Therapeutics PLC $SMMT Acquired by Neo Ivy Capital Management - MarketBeat

Nov 23, 2025
pulisher
Nov 21, 2025

(SMMT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Nov 21, 2025
pulisher
Nov 20, 2025

Summit C-Suite Risks Success, Akeso Wins Either Way (OTCMKTS:AKESF) - Seeking Alpha

Nov 20, 2025
pulisher
Nov 20, 2025

Jefferies Cuts Summit Therapeutics (SMMT) Price Target, Keeps Buy Rating - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

ProShare Advisors LLC Sells 25,455 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Nov 20, 2025
pulisher
Nov 19, 2025

Is Summit Therapeutics Inc. building a consolidation baseMarket Rally & Weekly Top Stock Performers List - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What MACD and RSI say about Summit Therapeutics Inc.Gap Up & Weekly Chart Analysis and Trade Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Summit: A Cautious Bet Backed By Anti-VEGF & Insider Buying (NASDAQ:SMMT) - Seeking Alpha

Nov 19, 2025
pulisher
Nov 19, 2025

Summit Therapeutics (NASDAQ:SMMT) Now Covered by Wolfe Research - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

Has Summit Therapeutics Inc. found a price floorJuly 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Wolfe Research Initiates Coverage of Summit Therapeutics (SMMT) with Peer Perform Recommendation - Nasdaq

Nov 18, 2025
pulisher
Nov 18, 2025

Summit Therapeutics at Jefferies London: Strategic Progress in Cancer Trials By Investing.com - Investing.com Canada

Nov 18, 2025
pulisher
Nov 18, 2025

Wolfe Research Initiates Coverage on SMMT with 'Peer Perform' Ra - GuruFocus

Nov 18, 2025
pulisher
Nov 18, 2025

Transcript : Summit Therapeutics Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 03 - MarketScreener

Nov 18, 2025
pulisher
Nov 18, 2025

Summit Therapeutics at Jefferies London: Strategic Progress in Cancer Trials - Investing.com

Nov 18, 2025
pulisher
Nov 16, 2025

What institutional flow reveals about Summit Therapeutics Inc.GDP Growth & Real-Time Buy Zone Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Candriam S.C.A. Sells 324,755 Shares of Summit Therapeutics PLC $SMMT - MarketBeat

Nov 16, 2025
$38.81
price up icon 1.44%
$96.10
price up icon 0.98%
$32.30
price up icon 3.39%
$96.00
price up icon 0.28%
biotechnology ONC
$320.84
price down icon 0.57%
$195.24
price up icon 2.84%
Kapitalisierung:     |  Volumen (24h):